Accurate cancer diagnosis possible with just a drop of blood
Liquid biopsy, which detects tumor DNAs in the blood, is not only more convenient than the biopsy that requires collection of patients' tissues, but is attracting much attention since the blood contains tumor DNAs in presence of any cancer in the body, whereas the tissue collection frequently misses cancerous cells.
Currently, polymerase chain reaction (PCR) is widely employed to detect a small number of mutated genes. However, there is a strong need to improve the reliability of the conventional method since its sensitivity and specificity are compromised especially at low pconcentrations.
A research team led by Professor Joon Won Park at POSTECH's Department of Chemistry in collaboration with Seoul National University College of Medicine and Seoul St. Mary's Hospital has shown that the use of an atomic force microscope overcomes such shortcomings.
The liquid biopsy method developed by the researchers demonstrates sensitivity high enough to detect even one to three specific tumor DNAs in the blood while showing specificity close to 100%.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.